Actively Recruiting

Age: 18Years - 80Years
All Genders
Healthy Volunteers
NCT05605314

Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye

Led by Peking University Third Hospital · Updated on 2022-11-04

500

Participants Needed

1

Research Sites

365 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Primary Sjögren's syndrome is a chronic autoimmune disease that primarily involves exocrine glands, most commonly manifested in dry eye, dry mouth, and in other systems of the body.

CONDITIONS

Official Title

Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must meet the TFOS DEWS II definition for dry eye disease
  • Participants in the pSS-DED group must meet the 2016 ACR/EULAR diagnosis and classification criteria for primary Sjogren's syndrome
Not Eligible

You will not qualify if you...

  • Diagnosis of any rheumatic or systemic diseases affecting tear function other than primary Sjogren's syndrome and dry eye disease
  • History of eye trauma or surgery
  • History of wearing contact lenses
  • Presence of other eye conditions such as acute inflammation, infection, glaucoma, or eyelid abnormalities
  • Inability to properly cooperate or complete required examinations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University Third Hospital

Beijing, China

Actively Recruiting

Loading map...

Research Team

Y

Yun Feng, PhD

CONTACT

W

Weizhen Zeng

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here